Full text is available at the source.
Prenatal Immune Challenge Differentiates the Effect of Aripiprazole and Risperidone on CD200–CD200R and CX3CL1–CX3CR1 Dyads and Microglial Polarization: A Study in Organotypic Cortical Cultures
Prenatal Immune Stress Changes How Aripiprazole and Risperidone Affect Brain Immune Signals and Microglial Response in Cortical Tissue
AI simplified
Abstract
Maternal immune activation (MIA) diminished the mRNA level of key regulatory components in organotypic cortical cultures.
- MIA affects the response of organotypic cortical cultures (OCCs) to additional stimulation with lipopolysaccharide (LPS).
- LPS downregulated the expression of specific genes and altered the mRNA levels of pro- and anti-inflammatory markers in both control and MIA OCCs.
- Risperidone treatment increased the expression of certain regulatory components in MIA OCCs.
- Aripiprazole elevated gene levels in control OCCs and showed a more pronounced effect on pro- and anti-inflammatory cytokines compared to risperidone in MIA OCCs.
- Both antipsychotics limited the increase in pro-inflammatory factors generated by LPS and enhanced the levels of anti-inflammatory components under certain conditions.
AI simplified